MagIA Diagnostics

Infectious diseases, caused by the transmission of a pathogen such as bacteria, viruses, parasites,  kill millions of people each year. Eradicate them is one of the biggest health priority worldwide (WHO, governments). Effective, accessible, massive screening solutions for the management of these diseases is the key. To treat, you need to screen. Today, we do not diagnose enough. One of the challenges of the 21st century is to find “the missing millions” people.

Most of the infectious disease diagnostic is still done in laboratories. Many manufacturers and healthcare practitioners have been pushing for decades to change that paradigm and to decentralize testing in what is called Point-Of-Care Testing (POCT) technologies, with out of lab, portables devices. But despite the enthusiasm for POCT, their adoption by clinicians remains limited :  strips tests are mostly mono-parametric, benchtop devices have limited portability, lab-on-chips suffer from manufacturing complexity and high prices …

Thanks to its micro-magnetic patented technology (6 patents) resulting from 15 years of research at CNRS, MagIA brings a solution answering to the limits of POCT screening. Designed with and for screening professionals, it allows a syndromic, multiplex diagnostic approach on truly portable, autonomous device for up to 6 analyses within 20mn using 50µL of capillary blood. In MagIA, we rather talk about On-the-Spot Screening as the solution is about reaching out-of-care populations.